NCT04402125

Brief Summary

The project is a 6-month prospective Randomized Controlled Trial evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=80) vs. wait-list (WL, N=80) control in African American men who have experienced a stroke or TIA within the past 5 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started May 2020

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2020

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 26, 2020

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2025

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

5.3 years

First QC Date

May 15, 2020

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • TEAM vs WL change in systolic BP

    TEAM vs WL change in systolic BP

    Baseline to 6-month follow up

Secondary Outcomes (7)

  • TEAM vs WL change in diastolic BP

    Baseline to 6-month follow up

  • TEAM vs WL change in cholesterol

    Baseline to 6-month follow up

  • TEAM vs WL change in HDL

    Baseline to 6-month follow up

  • TEAM vs WL change in LDL

    Baseline to 6-month follow up

  • TEAM vs WL change in triglycerides

    Baseline to 6-month follow up

  • +2 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Participants randomized to TEAM intervention for 6 months, then observed for 6 month follow up

Behavioral: TargEted MAnageMent Intervention (TEAM)

Waitlist

OTHER

Participants randomized to waitlist for 6 months, then offered the intervention for 6 months

Behavioral: TargEted MAnageMent Intervention (TEAM)

Interventions

TEAM targets acquisition of self-management expertise and use of healthy behaviors that are intended to reduce stroke risk and burden. TEAM participants will continue in their regular medical care, supplemented by the TEAM intervention. Components are as follows: 1. A 60 minute initial session in which the nurse and the PED meet with the patient who has experienced stroke or TIA. The initial session will cover introductions, orientation, and logistic planning. 2. Five 60-minute group sessions with 6-10 stroke survivors (and their care partners as applicable) held approximately 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 week after enrollment. Sessions are co-lead by a nurse and a PED. 3. Six brief telephone sessions implemented after the conclusion of the 5 TEAM group sessions. Calls will be conducted every 2 weeks for 12 weeks. Calls will reinforce group session content, provide social support and facilitate linkage with other care providers.

InterventionWaitlist

Eligibility Criteria

Age18 Years - 90 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age range 18 to 90
  • Self-identified African American male
  • Have had a stroke or TIA in the past 10 years based on date of hospital discharge from an acute stroke program or Emergency Room/physician visit for TIA
  • Barthel Index (BI) score of \>= 40
  • Able to participate in group sessions
  • Age range from 18 to 90
  • Able to participate in group sessions
  • Age range: from 18 to 90
  • Self-identified African American male
  • Have had a stroke or TIA
  • Able to participate in group sessions
  • Age range: from 18 to 90
  • Able to participate in group sessions
  • Is either a family member, friend or other individual who is important in an enrolled peer educator's stroke recovery OR the family member, friend or other individual of someone who has had a stroke or TIA and is/was important in their stroke recovery

You may not qualify if:

  • Individuals who are unable or unwilling to provide written informed consent
  • Individuals who have had stroke due to sickle-cell disease
  • Individuals who are unable or unwilling to provide written informed consent
  • Individuals who have had stroke due to sickle-cell disease
  • \. Individuals who are unable or unwilling to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Case Western Reserve University

Cleveland, Ohio, 44106, United States

Location

Related Publications (1)

  • Still CH, Burant C, Moore S, Einstadter D, Killion C, Modlin C, Sundararajan S, Thornton JD, Wright JT Jr, Sajatovic M. The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled Trial. J Multidiscip Healthc. 2021 Feb 23;14:513-522. doi: 10.2147/JMDH.S288753. eCollection 2021.

MeSH Terms

Conditions

StrokeIschemic Attack, Transient

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain Ischemia

Study Officials

  • Martha Sajatovic, MD

    Case Western Reserve University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: 80 participants are assigned to receive TEAM, and 80 participants are assigned to wait list
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 15, 2020

First Posted

May 26, 2020

Study Start

May 5, 2020

Primary Completion

September 8, 2025

Study Completion

September 8, 2025

Last Updated

May 4, 2026

Record last verified: 2026-04

Locations